title: Use of Org 10,172 in the treatment of heparin-induced thrombocytopenia and thrombosis.
authors.forename: L
authors.initials: L
authors.lastname: Kiers
authors.forename: L E
authors.initials: LE
authors.lastname: Grigg
authors.forename: J F
authors.initials: JF
authors.lastname: Cade
authors.forename: P R
authors.initials: PR
authors.lastname: Street
authors.forename: B H
authors.initials: BH
authors.lastname: Chong
mesh_terms: D000368:Aged; D002809:Chondroitin Sulfates; D003871:Dermatan Sulfate; D005260:Female; D006025:Glycosaminoglycans / Q000627:therapeutic use*; D006493:Heparin / Q000009:adverse effects*; D006497:Heparan Sulfate; D006801:Humans; D013921:Thrombocytopenia / Q000139:chemically induced / Q000188:drug therapy*; D013924:Thrombophlebitis / Q000139:chemically induced / Q000188:drug therapy*
chemical_list: D002809:Chondroitin Sulfates; D003871:Dermatan Sulfate; D006025:Glycosaminoglycans; D006493:Heparin; D006497:Heparan Sulfate; C035838:danaparoid